Atlas Trials

A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes

Clinical trial NCT04956263 · COMPLETED

Trial details

NCT number
NCT04956263
Sponsor
Youngene Therapeutics Inc., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 1Type1diabetesDiabetes Mellitus
Start date
2021-06-17
Primary completion
2022-02-02
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.